See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for David Anderson

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	38874073	0	Tunehag KR, Thomas CD, Franchi F, et al. CYP2C19 Genotype Is Associated With Adverse Cardiovascular Outcomes in Black Patients Treated With Clopidogrel Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2024 Jun 14:e033791. doi: 10.1161/JAHA.123.033791.
	37801772	0	Xu Y, Khan F, Kovacs MJ, et al. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012.
	36710196	0	Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021.
	35920155	0	McCullough-Hicks ME, Halterman DJ, Anderson D, et al. High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients With COVID-19 Infection. Stroke. 2022 Aug 3:101161STROKEAHA122038955. doi: 10.1161/STROKEAHA.122.038955.
	35679460	0	Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027.
	35429163	0	Thomas CD, Franchi F, Keeley EC, et al. Impact of the ABCD-GENE Score on Clopidogrel Clinical Effectiveness after PCI: A Multi-site, Real-world Investigation. Clin Pharmacol Ther. 2022 Apr 16. doi: 10.1002/cpt.2612.
	35264372	0	Marcucci M, Etxeandia-Ikobaltzeta I, Yang S, et al. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials. BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785.
	35217534	0	Cohen KR, Anderson D, Ren S, et al. Contribution of the elevated thrombosis risk of males to the excess male mortality observed in COVID-19: an observational study. BMJ Open. 2022 Feb 25;12(2):e051624. doi: 10.1136/bmjopen-2021-051624.
	34521104	0	Nieuwlaat R, Wiercioch W, Brozek JL, et al. How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Adv. 2021 Sep 14. pii: S2473-9529(21)00555-3. doi: 10.1182/bloodadvances.2020003577.
	34284102	0	Morgano GP, Wiercioch W, Anderson DR, et al. A modeling approach to derive baseline risk estimates for GRADE recommendations: Concepts, development, and results of its application to the American Society of Hematology 2019 guidelines on prevention of venous thromboembolism in surgical hospitalized patients. J Clin Epidemiol. 2021 Jul 18;140:69-78. doi: 10.1016/j.jclinepi.2021.07.010.
	34108229	0	Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
	33724705	0	Aziz D, Skeith L, Rodger MA, et al. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21.
	33280553	0	Hussein HM, Anderson DC. Small Vessel Disease: Perpetrator or Predictor of Stroke in Patients With Atrial Fibrillation? Stroke. 2021 Jan;52(1):100-102. doi: 10.1161/STROKEAHA.120.032536. Epub 2020 Dec 7.
	32574367	0	Yepes-Nunez JJ, Rajasekhar A, Rahman M, et al. Pharmacologic thromboprophylaxis in adult patients undergoing neurosurgical interventions for preventing venous thromboembolism. Blood Adv. 2020 Jun 23;4(12):2798-2809. doi: 10.1182/bloodadvances.2020002195.
	32453843	0	Wiercioch W, Nieuwlaat R, Akl EA, et al. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020 May 26;4(10):2351-2365. doi: 10.1182/bloodadvances.2020001768.
	32433797	0	Takada T, van Doorn S, Parpia S, et al. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: An individual participant data meta-analysis. J Thromb Haemost. 2020 Sep;18(9):2245-2252. doi: 10.1111/jth.14900. Epub 2020 Jul 8.
	31794602	0	Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975.
	30349885	0	Ma KA, Kahn SR, Akaberi A, et al. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study. Res Pract Thromb Haemost. 2018 Jun 17;2(4):670-677. doi: 10.1002/rth2.12123. eCollection 2018 Oct.
	29742368	0	Anderson DR, Doucette S, Kahn SR. Venous Thromboembolism Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 May 10;378(19):1848-1849. doi: 10.1056/NEJMc1803708.
	29607251	0	Grote CW, Cowan PC, Anderson DW, et al. Pseudotumor from Metal-on-Metal Total Hip Arthroplasty Causing Unilateral Leg Edema: Case Presentation and Literature Review. Biores Open Access. 2018 Mar 1;7(1):33-38. doi: 10.1089/biores.2017.0035. eCollection 2018.
	29466159	0	Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.
	29279816	0	Mojadidi MK, Mahmoud AN, Elgendy AY, et al. When Ablation Is Not the Answer: Acute Left Main Thrombosis Causing Incessant Ventricular Tachycardia Following Left Ventricular Assist Device Implant. Cureus. 2017 Oct 21;9(10):e1790. doi: 10.7759/cureus.1790.
	29224973	0	Wan T, Rodger M, Zeng W, et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. Thromb Res. 2018 Feb;162:104-109. doi: 10.1016/j.thromres.2017.11.020. Epub 2017 Dec 8.
	28680172	0	Al Saleh AS, Berrigan P, Anderson D, et al. Direct Oral Anticoagulants and Vitamin K Antagonists for Treatment of Deep Venous Thrombosis and Pulmonary Embolism in the Outpatient Setting: Comparative Economic Evaluation. Can J Hosp Pharm. 2017 May-Jun;70(3):188-199. doi: 10.4212/cjhp.v70i3.1658. Epub 2017 Jun 30.
	28460853	0	Agarwal N, Jain A, Mahmoud AN, et al. Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention. Am J Med. 2017 Nov;130(11):1280-1289. doi: 10.1016/j.amjmed.2017.03.057. Epub 2017 Apr 29.
	28314731	0	Nairooz R, Saad M, Elgendy IY, et al. Long-term outcomes of provisional stenting compared with a two-stent strategy for bifurcation lesions: a meta-analysis of randomised trials. Heart. 2017 Sep;103(18):1427-1434. doi: 10.1136/heartjnl-2016-310929. Epub 2017 Mar 17.
	28314711	0	Rodger MA, Le Gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.
	27621493	0	Al Saleh AS, Anderson D. Inadvertent Overdose of Low-Molecular-Weight Heparin in an Elderly Patient with Deep Vein Thrombosis and Acute Kidney Injury. Can J Hosp Pharm. 2016 Jul-Aug;69(4):320-2. doi: 10.4212/cjhp.v69i4.1581. Epub 2016 Aug 31.
	27318246	0	Ma K, Wells P, Guzman C, et al. A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Thromb Res. 2016 Aug;144:100-5. doi: 10.1016/j.thromres.2016.04.014. Epub 2016 Apr 26.
	27086275	0	Rodger MA, Scarvelis D, Kahn SR, et al. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort. Thromb Res. 2016 Jul;143:152-8. doi: 10.1016/j.thromres.2016.03.028. Epub 2016 Mar 29.
	27031923	0	Gauthier K, Le Gal G, Shivakumar S, et al. Inter-observer reliability of the HERDOO2 clinical decision rule. Thromb Res. 2016 May;141:136-8. doi: 10.1016/j.thromres.2016.03.015. Epub 2016 Mar 15.
	25935313	0	Anderson DC, Asinger RW. Atrial Fibrillation and Stroke: It's About Point of View. J Stroke Cerebrovasc Dis. 2015 Jun;24(6):1118-9. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.003. Epub 2015 Apr 30.